You could almost hear the collective sigh of media relief when delivering the welcome news of the arrival of vaccines to treat Covid-19.
But the vaccine honeymoon is proving short-lived. It was always going to be a political and economic football, given the priorities and power of different players: nation states, drug companies and health authorities both national and international. To say nothing of the world’s desperate citizenry. The problems are myriad: vaccine nationalism, rollout priorities, supply issues, timing booster shots, predatory behaviour by Big Pharma and new variants of this shape-shifting virus.
